3 Reasons Lyft Is a Better Buy Than Uber
Uber may be the big, bad wolf of ridesharing; Lyft is the better buy by a mile.
Editors' Picks
Wide-Body Jet Orders Jump at Airbus and Boeing in July
The downturn in orders at Airbus and Boeing this year hasn't affected the pricey wide-body jets that they're most desperate to sell.
Why This Oil Stock Believes It Will Be a Big Winner Over the Long Term
Hess is about to start up a massive cash flow growth engine.
How Big Is Celgene's Latest Good News?
FDA approval of fedratinib could lead to significantly more revenue for the biotech. But even better news could be on the way.
Recent articles
3 Reasons Lyft Is a Better Buy Than Uber
Uber may be the big, bad wolf of ridesharing; Lyft is the better buy by a mile.
Disney World Needs Galaxy's Edge to Succeed
Passholder previews for Star Wars: Galaxy's Edge kicked off at Disney's Hollywood Studios in Florida this weekend.
Hulu Is Rapidly Becoming a Force in Pay-TV
The Disney-controlled streaming service added 300,000 live television subscribers last quarter as its competitors lost customers.
Wide-Body Jet Orders Jump at Airbus and Boeing in July
The downturn in orders at Airbus and Boeing this year hasn't affected the pricey wide-body jets that they're most desperate to sell.
Have These Tumbling Cannabis Stocks Hit Bottom Yet?
Here's what needs to happen if these marijuana stocks are going to come bouncing back.
Why This Oil Stock Believes It Will Be a Big Winner Over the Long Term
Hess is about to start up a massive cash flow growth engine.
This High-Yield Renewable Energy Stock Has Powered Up the Dividend Growth Engine
Brookfield Renewable Partners has been very active on the strategic front in recent months.
Lowe's Earnings Preview: Seeking Balanced Growth
The home improvement giant will update investors on its 2019 outlook on Wednesday.
Switching Jobs Might Boost Your Salary -- but Will You Lose Money in Other Ways?
Don't just look at a single number when deciding whether to accept a new position.
Healthcare REITs: A Boom Is Coming
Ventas took a close look at the senior housing market and sees good things ahead for the healthcare real estate investment trust niche.
Baidu Stock Has a Lot to Prove This Week
China's leading search engine reports its second-quarter results on Monday night. The report doesn't have to be perfect for investors to win, with the stock at a six-year low.
Is Amgen a Buy?
The biotech's present and future might not live up to its past.
Is Union Pacific Stock a Buy?
The railroad stock offers a decent dividend and has earnings growth opportunities in the coming years.
Target Earnings: What to Watch
Investors are expecting an aggressive outlook from the retailer on Wednesday.
Will Buybacks Propel Booking Holdings' Stock Price?
Growth is slowing, but the company is using cash flow to buy back gobs of its stock.
10 Marijuana Stocks Wall Street Thinks Will Double
With up to 196% upside, should these cannabis stocks be in your portfolio?
Why This 5.1%-Yielding Dividend Stock Is So Excited About What Lies Ahead
Pipeline giant ONEOK is about to hit an inflection point.
Here's How Shockingly Low the Odds of U.S. Marijuana Legalization Really Are
Investors, don't bet on U.S. legalization of pot anytime soon.
Better Buy: Aurora Cannabis vs. Cronos Group
They're two of the most-followed cannabis stocks on the market. But which is the better pick for long-term investors?
How Big Is Celgene's Latest Good News?
FDA approval of fedratinib could lead to significantly more revenue for the biotech. But even better news could be on the way.